BioSpace News Archive

Rising adoption of immunoprecipitation technique along with intensifying proteomics and genomics research is expected to boost magnetic beads market growth.

SIA (Surgical Innovation Associates), an early growth-stage medical technology company, announced today that the first patient has been enrolled in a pivotal trial of its flagship absorbable mesh, DuraSorb®, under an investigational device exemption (IDE) from the United States Food and Drug Administration (US FDA).

OrthoGrid® Systems, Inc., a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the launch of its new OrthoGrid Hip software application after receiving FDA clearance on February 18, 2021.

The Lung Cancer Research Foundation announced a collaboration with AstraZeneca to fund over $900,000 in research grants focused on understanding resistance to epidermal growth factor receptor tyrosine kinase inhibitors and immune checkpoint inhibitors, including therapeutic approaches to overcome these mechanisms, as well as biomarkers of immune-mediated adverse events.

NeuroRx to File for Emergency Use Authorization in This Patient Population if Positive Results Continue to be Demonstrated at Day-60 Endpoint in Line with FDA’s New Guidance

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and G+FLAS Life Sciences, Inc., a biotechnology company developing research tools and reagents associated with CRISPR technology, announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

Brickell Biotech, Inc., a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, announced that it will report its financial results for the fourth quarter and full year ended December 31, 2020, after the market close on Tuesday, March 9, 2021.

Viemed Healthcare, Inc., a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that it will host its Year End Conference Call on Wednesday, March 3, 2021 at 11:00 a.m.

Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, announced that Dr. Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer, will participate in a fireside chat at the upcoming virtual SVB Leerink 10th Annual Global Healthcare Conference on Wednesday, February 24, 2021 at 12:00 PM EST.

In the midst of the COVID-19 pandemic, we continued to support our patients and healthcare providers with critical genetic insights needed to drive better health outcomes.